123 related articles for article (PubMed ID: 34822797)
1. The role of tumor acidification in aggressiveness, cell dissemination and treatment resistance of oral squamous cell carcinoma.
de Bem Prunes B; Nunes JS; da Silva VP; Laureano NK; Gonçalves DR; Machado IS; Barbosa S; Lamers ML; Rados PV; Kurth I; Hess J; Jou A; Visioli F
Life Sci; 2022 Jan; 288():120163. PubMed ID: 34822797
[TBL] [Abstract][Full Text] [Related]
2. Acquisition cancer stemness, mesenchymal transdifferentiation, and chemoresistance properties by chronic exposure of oral epithelial cells to arecoline.
Wang TY; Peng CY; Lee SS; Chou MY; Yu CC; Chang YC
Oncotarget; 2016 Dec; 7(51):84072-84081. PubMed ID: 27557511
[TBL] [Abstract][Full Text] [Related]
3. Silencing JARID1B suppresses oncogenicity, stemness and increases radiation sensitivity in human oral carcinoma.
Lin CS; Lin YC; Adebayo BO; Wu A; Chen JH; Peng YJ; Cheng MF; Lee WH; Hsiao M; Chao TY; Yeh CT
Cancer Lett; 2015 Nov; 368(1):36-45. PubMed ID: 26184998
[TBL] [Abstract][Full Text] [Related]
4. Crosstalk between Raf-MEK-ERK and PI3K-Akt-GSK3β signaling networks promotes chemoresistance, invasion/migration and stemness via expression of CD44 variants (v4 and v6) in oral cancer.
Kashyap T; Pramanik KK; Nath N; Mishra P; Singh AK; Nagini S; Rana A; Mishra R
Oral Oncol; 2018 Nov; 86():234-243. PubMed ID: 30409306
[TBL] [Abstract][Full Text] [Related]
5. Neuropilin-1 promotes epithelial-to-mesenchymal transition by stimulating nuclear factor-kappa B and is associated with poor prognosis in human oral squamous cell carcinoma.
Chu W; Song X; Yang X; Ma L; Zhu J; He M; Wang Z; Wu Y
PLoS One; 2014; 9(7):e101931. PubMed ID: 24999732
[TBL] [Abstract][Full Text] [Related]
6. The Antihelminthic Niclosamide Inhibits Cancer Stemness, Extracellular Matrix Remodeling, and Metastasis through Dysregulation of the Nuclear β-catenin/c-Myc axis in OSCC.
Wang LH; Xu M; Fu LQ; Chen XY; Yang F
Sci Rep; 2018 Aug; 8(1):12776. PubMed ID: 30143678
[TBL] [Abstract][Full Text] [Related]
7. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
[TBL] [Abstract][Full Text] [Related]
8. Targeted blockade of interleukin-8 negates metastasis and chemoresistance via Akt/Erk-NFκB axis in oral cancer.
Joshi S; Pandey R; Kumar A; Gupta V; Arya N
Cytokine; 2023 Jun; 166():156155. PubMed ID: 37088002
[TBL] [Abstract][Full Text] [Related]
9. ADAR1 promotes the epithelial-to-mesenchymal transition and stem-like cell phenotype of oral cancer by facilitating oncogenic microRNA maturation.
Liu X; Fu Y; Huang J; Wu M; Zhang Z; Xu R; Zhang P; Zhao S; Liu L; Jiang H
J Exp Clin Cancer Res; 2019 Jul; 38(1):315. PubMed ID: 31315644
[TBL] [Abstract][Full Text] [Related]
10. Markedly increased Oct4 and Nanog expression correlates with cisplatin resistance in oral squamous cell carcinoma.
Tsai LL; Yu CC; Chang YC; Yu CH; Chou MY
J Oral Pathol Med; 2011 Sep; 40(8):621-8. PubMed ID: 21342274
[TBL] [Abstract][Full Text] [Related]
11. Suppression of miR-204 enables oral squamous cell carcinomas to promote cancer stemness, EMT traits, and lymph node metastasis.
Yu CC; Chen PN; Peng CY; Yu CH; Chou MY
Oncotarget; 2016 Apr; 7(15):20180-92. PubMed ID: 26933999
[TBL] [Abstract][Full Text] [Related]
12. The acidic tumor microenvironment drives a stem-like phenotype in melanoma cells.
Andreucci E; Peppicelli S; Ruzzolini J; Bianchini F; Biagioni A; Papucci L; Magnelli L; Mazzanti B; Stecca B; Calorini L
J Mol Med (Berl); 2020 Oct; 98(10):1431-1446. PubMed ID: 32803272
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological inhibition of HDAC6 overcomes cisplatin chemoresistance by targeting cancer stem cells in oral squamous cell carcinoma.
Tavares MO; Milan TM; Bighetti-Trevisan RL; Leopoldino AM; de Almeida LO
J Oral Pathol Med; 2022 Jul; 51(6):529-537. PubMed ID: 35678235
[TBL] [Abstract][Full Text] [Related]
14. The role of NLRP3 inflammasome in 5-fluorouracil resistance of oral squamous cell carcinoma.
Feng X; Luo Q; Zhang H; Wang H; Chen W; Meng G; Chen F
J Exp Clin Cancer Res; 2017 Jun; 36(1):81. PubMed ID: 28637493
[TBL] [Abstract][Full Text] [Related]
15. Lipopolysaccharide enhances OSCC migration by promoting epithelial-mesenchymal transition.
He Z; Deng R; Huang X; Ni Y; Yang X; Wang Z; Hu Q
J Oral Pathol Med; 2015 Oct; 44(9):685-92. PubMed ID: 25367215
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of MDR- and EMT-Related Molecules in Cisplatin-Resistant Human Oral Squamous Cell Carcinoma Cell Lines.
Choi HS; Kim YK; Yun PY
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31234332
[TBL] [Abstract][Full Text] [Related]
17. RNA interference of long noncoding RNA HOTAIR suppresses autophagy and promotes apoptosis and sensitivity to cisplatin in oral squamous cell carcinoma.
Wang X; Liu W; Wang P; Li S
J Oral Pathol Med; 2018 Nov; 47(10):930-937. PubMed ID: 30053324
[TBL] [Abstract][Full Text] [Related]
18. Fractionated irradiation induces radioresistant oral carcinoma cells with enhanced malignant phenotypes.
Liu Y; Sun T; Yang J; Luo J; Zhou H
Arch Oral Biol; 2024 Aug; 164():105988. PubMed ID: 38788293
[TBL] [Abstract][Full Text] [Related]
19. MUC1 gene silencing inhibits proliferation, invasion, and migration while promoting apoptosis of oral squamous cell carcinoma cells.
Zhang AM; Chi XH; Bo ZQ; Huang XF; Zhang J
Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31439759
[TBL] [Abstract][Full Text] [Related]
20. CD47-SIRPα Signaling Induces Epithelial-Mesenchymal Transition and Cancer Stemness and Links to a Poor Prognosis in Patients with Oral Squamous Cell Carcinoma.
Pai S; Bamodu OA; Lin YK; Lin CS; Chu PY; Chien MH; Wang LS; Hsiao M; Yeh CT; Tsai JT
Cells; 2019 Dec; 8(12):. PubMed ID: 31861233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
